{
    "clinical_study": {
        "@rank": "74097", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      Purify and characterize a testis-stimulating factor in the blood of adult volunteers who had\n      precocious puberty as boys."
        }, 
        "brief_title": "Purification of Testis-Stimulating Factor in Precocious Puberty", 
        "condition": "Precocious Puberty", 
        "condition_browse": {
            "mesh_term": "Puberty, Precocious"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Subjects are treated for 2 months with depot injections of leuprolide\n      acetate every 4 weeks and testosterone replacement every 2 weeks.  Hormone levels are tested\n      every other week.\n\n      If luteinizing hormone and follicular-stimulating hormone levels are at or below detection\n      on day 56, blood is drawn for a testis-stimulating factor bioassay and subsequent factor\n      purification and characterization.\n\n      Volunteers are asked to repeat this 2-month procedure no more than 2 times every 12 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        Adult men diagnosed with precocious puberty (familial testotoxicosis) as boys"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "4", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004344", 
            "org_study_id": "199/11903", 
            "secondary_id": "OHSU-3328"
        }, 
        "intervention": [
            {
                "intervention_name": "leuprolide", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "testosterone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Testosterone", 
                "Testosterone enanthate", 
                "Testosterone undecanoate", 
                "Testosterone 17 beta-cypionate", 
                "Methyltestosterone", 
                "Leuprolide"
            ]
        }, 
        "keyword": [
            "endocrine disorders", 
            "precocious puberty", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Oregon Health and Science University", 
            "last_name": "Barry Albertson", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004344"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Oregon Health and Science University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "January 1997", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "February 2000"
    }, 
    "geocoordinates": {}
}